Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. May 14, 2016; 22(18): 4547-4558
Published online May 14, 2016. doi: 10.3748/wjg.v22.i18.4547
Table 1 Distribution of hepatitis C virus-related cases of advanced fibrosis/fibrosing cholestatic hepatitis cases after liver transplantation with and without liver retransplantation according to center n (%)
Centern (LT)LT related to HCV (percent of total LT)F3/F4/FCH after LT (percent of LT for HCV)F3/F4/FCH reLT (percent of LT for HCV)F3/F4/FCH without ReLT (percent of LT for HCV)
11933770 (40)174 (23)31 (4)143 (19)
22001420 (21)108 (26)26 (6)82 (20)
32124412 (19)20 (5)12 (3)8 (2)
41477321 (22)40 (12)11 (3)29 (9)
5920247 (27)33 (13)10 (4)23 (9)
61576141 (9)16 (11)8 (6)8 (6)
7450143 (32)16 (11)8 (6)8 (6)
8860132 (15)8 (6)2 (2)6 (5)
Total113412586 (23)415 (16)108 (4)307 (12)

  • Citation: Song ATW, Sobesky R, Vinaixa C, Dumortier J, Radenne S, Durand F, Calmus Y, Rousseau G, Latournerie M, Feray C, Delvart V, Roche B, Haim-Boukobza S, Roque-Afonso AM, Castaing D, Abdala E, D’Albuquerque LAC, Duclos-Vallée JC, Berenguer M, Samuel D. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. World J Gastroenterol 2016; 22(18): 4547-4558
  • URL: https://www.wjgnet.com/1007-9327/full/v22/i18/4547.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v22.i18.4547